Compare Mesoblast Limited (MESO) vs Pinterest Inc (PINS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Pinterest Inc — how do they compare? Mesoblast Limited trades at $16.32 (market cap $2.17B), while Pinterest Inc trades at $22.81 (market cap $12.78B). The key difference: Pinterest Inc is far larger — about 5.9× Mesoblast Limited's market cap, and Mesoblast Limited is trading nearer its 52-week high, Pinterest Inc nearer its low. Which is the better fit depends on your goals.
| MESO | PINS | |
|---|---|---|
Market Cap | $2.17B | $12.78B |
Sector | Technology | Media |
52-Week High | $20.96 | $39.17 |
52-Week Low | $12.88 | $15.42 |
Enterprise Value | $2.17B | $12.68B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MESO trades at $16.63, down 3.98% on the day, with a bullish technical outlook supported by moving averages. The company shows strong revenue growth with Ryoncil generating $115 million in annual revenue, though it remains unprofitable with a net loss of $102 million. Recent developments include positive Phase 3 trial progress and FDA BLA filings for new treatments.
Investment outlook balances promising pipeline progress against significant financial losses. The stock offers growth potential through commercial expansion but carries substantial risk from continued cash burn and regulatory hurdles. Analyst consensus leans bullish with 45% buy ratings, reflecting optimism about the company's transition to commercial-stage operations.
Pinterest (PINS) trades at $22.98, down 0.95% on the day, with technical indicators showing a bullish trend supported by moving averages. The company reported strong revenue growth, reaching $4.22B in 2025 with improving profitability margins. Recent news highlights director stock sales and upcoming Q2 2026 earnings, while analyst consensus remains positive with a $27.53 price target.
PINS presents a growth opportunity with solid fundamentals and bullish technicals, though risks include competitive pressures and insider selling. The stock trades below analyst targets, offering potential upside if earnings momentum continues. Key catalysts include Q2 results and e-commerce integration progress.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →
